Parkman Healthcare Partners’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Parkman Healthcare Partners’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-81,573	Closed	-$9.41M	–	102
2020 Q4	$9.41M	Buy	81,573 +31,573	+63%	+$3.54M	2.41%	12
2020 Q3	$4.87M	Sell	50,000 -69,778	-58%	-$8.03M	1.29%	34
2020 Q2	$14.7M	Sell	119,778 -3,000	-2%	-$340K	4.14%	2
2020 Q1	$10.8M	Buy	122,778 +27,778	+29%	+$2.94M	4.98%	3
2019 Q4	$9.93M	Buy	+95,000	New	+$10.7M	2.87%	8

Other funds holding GWPH

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Parkman Healthcare Partners's GWPH Position: Q1 2021 in Review

Parkman Healthcare Partners sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2021, closing a stake of 81,573 shares — an estimated $9.41M sold.

Parkman Healthcare Partners first reported a position in GWPH in Q4 2019 and held it in 5 quarters. The position peaked at $14.7M in Q2 2020. 297 funds tracked by Wall St. Rank hold GWPH as of Q1 2021.

Parkman Healthcare Partners reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2021 after selling out during the quarter.
Parkman Healthcare Partners sold 81,573 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2021, an estimated $9.41M.
Parkman Healthcare Partners first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2019 and held it in 5 quarters.
Parkman Healthcare Partners's GW Pharmaceuticals Plc American Depositary Shares position peaked at $14.7M in Q2 2020.
297 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2021.

Based on Parkman Healthcare Partners's 13F filing for Q1 2021, filed 14 May 2021.